Ovarian cancerous diseases are a medical problematic aspect that in today’s day to day life causes a very big trouble. It is claimed by the International Statistics Association that more than one hundred thousand women are year by year diagnosed with the ovarian cancer and this number does not include the other fifty two thousand suffering ones which will eventually lose their lives by the end of this year alone.

The main apparition causes are still a medical baffling mystery and this can reflect in the fact that the same treatment measures are delivered with not so many improvements.

There are constant researches that are done in order to understand the essence of the cancerous diseases and how they work, develop and influence the whole reproductive system. It is more and more of a problem and as the science in this field advances there are even more questions that are left unanswered.


There are certain answers that the whole medical community that performs operations in this direction hopes to find in the short term, or as fast as possible. It is not just about finding a cure for the cancerous diseases altogether but also with the whole structure and the whole pharmaceutical industry that can improve in what we recall as financial benefits.


A company that will eventually deliver the orally ingested, standard or universally accepted cancer treatment measure will be in the lead between all other companies in this world and this will eventually mean a lot for the whole global communities of people who are suffering or want to prevent future cases, in the presumption that the DNA gene with the cancerous info is embedded in them, from first or second degree relatives or have in their medical history a previous cancerous form that was removed (in this particular cases, the gene already knows all about the disease and has a forty percent chances of redeveloping the affection after a certain amount of time.) One prescribed medication is the Avastin.


There are other issues at hand here, and this is a main concern from a financial point of view because the whole research that these companies are doing in the direction of finding a universally accepted treatment for cancer can be not so cost effective in the long run.


The medical staff specialized gynecologists along with the oncology ones are claiming that the cancer will be cured with oral medication measures, in at least ten years, in other words we are at least one decade away from the actual cure for cancer.


The present alternatives are more barbaric in nature, if we take in to consideration the negative side effects of chemo therapy and all the pains and discomfort that one feels.


Avastin for ovarian cancer is a futuristic alternative to the chemo and has no particular side effects but it is used mostly in the first phases of the disease.